Dynamics of Serum Inflammatory Markers Predict Survival After Definitive Chemoradiotherapy for Locally Advanced Cervical Cancer
Asia-Pacific Journal of Clinical Oncology · 2026
DOI: 10.1111/ajco.14201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asia-Pacific Journal of Clinical Oncology, 2026. Verfasst von Young Sub Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hospital Pathology, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Chemoradiotherapy, Biomarkers, Tumor, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: The Catholic Medical Center Research Foundation.
Abstract (Originalsprache)
Aim
Cervical cancer is caused by persistent infection with the human papillomavirus. This study aimed to investigate whether the changes in serum inflammatory markers between baseline and posttreatment can predict survival in cervical cancer undergoing definitive chemoradiotherapy (CCRT).
Methods
Eighty‐one Stage IB–IVA cervical cancer patients treated with definitive CCRT, with serum inflammatory markers obtained at diagnosis and after completion of pre‐planned therapy, were included. The percent changes of post‐/pretreatment levels × 100% were calculated for neutrophil‐to‐lymphocyte ratio (NLR), platelet‐to‐lymphocyte ratio (PLR), monocyte‐to‐lymphocyte ratio (MLR), systemic inflammation response index (SIRI), and systemic immune‐inflammation index (SII). The cutoffs were obtained with the maximal chi‐square statistics.
Results
At a median follow‐up of 28 months, the 2‐year overall survival (OS) was 75.4%. The 2‐year OS for patients with low versus high percent change was as follows: post‐/pre‐NLR (87.7% vs. 67.8%), post‐/pre‐MLR (75.9% vs. 71.1%), post‐/pre‐SIRI (76.5% vs. 61.7%), and post‐/pre‐SII (91.7% vs. 67.2%) (all p < 0.05). The hazard ratios (HR) in multivariate analysis were as follows: post‐/pre‐NLR (5.53, 95% confidence interval [CI]: 1.65–18.52), post‐/pre‐MLR (3.39, 95% CI: 1.39–8.26), post‐/pre‐SIRI (5.11, 95% CI: 1.92–13.57), and post‐/pre‐SII (6.57, 95% CI: 1.77–24.36) (all p < 0.05).
Conclusion
This study demonstrates the impact of the dynamics of serum inflammatory markers on survival. It has been consistently demonstrated across the markers. To adopt these markers for personalized treatment decisions, a better understanding of their relation with the actual tumor microenvironment is warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hospital Pathology, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
- Department of Obstetrics and Gynecology, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
- Department of Obstetrics and Gynecology, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
- Department of Radiation Oncology, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
- Department of Radiation Oncology, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
- Department of Hospital Pathology, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
ORCID-Profile: Young Sub Lee
Förderung
- The Catholic Medical Center Research Foundation
Zitieren
APA
Lee, Y. S., Kim, C. J., Kim, J. H., Lee, Y. S., Jeong, S., Lee, S. W., & Yim, K. (2026). Dynamics of Serum Inflammatory Markers Predict Survival After Definitive Chemoradiotherapy for Locally Advanced Cervical Cancer. Asia-Pacific Journal of Clinical Oncology. https://doi.org/10.1111/ajco.14201
Vancouver
Lee YS, Kim CJ, Kim JH, Lee YS, Jeong S, Lee SW, et al. Dynamics of Serum Inflammatory Markers Predict Survival After Definitive Chemoradiotherapy for Locally Advanced Cervical Cancer. Asia-Pacific Journal of Clinical Oncology. 2026. doi:10.1111/ajco.14201
BibTeX
@article{Lee2026,
author = {Lee, Young Sub and Kim, Chan Joo and Kim, Jin-Hwi and Lee, Yong Seok and Jeong, Songmi and Lee, Sea-Won and Yim, Kwangil},
title = {Dynamics of Serum Inflammatory Markers Predict Survival After Definitive Chemoradiotherapy for Locally Advanced Cervical Cancer},
journal = {Asia-Pacific Journal of Clinical Oncology},
year = {2026},
doi = {10.1111/ajco.14201}
}
EUVIMED